Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Anti-IL-13Rα2 therapy promotes recovery in a murine model of inflammatory bowel disease.

Karmele EP, Pasricha TS, Ramalingam TR, Thompson RW, Gieseck RL 3rd, Knilans KJ, Hegen M, Farmer M, Jin F, Kleinman A, Hinds DA; 23andMe Research Team, Almeida Pereira T, de Queiroz Prado R, Bing N, Tchistiakova L, Kasaian MT, Wynn TA, Vannella KM.

Mucosal Immunol. 2019 Sep;12(5):1174-1186. doi: 10.1038/s41385-019-0189-6. Epub 2019 Jul 15.

2.

Fibroblast-specific integrin-alpha V differentially regulates type 17 and type 2 driven inflammation and fibrosis.

Sciurba JC, Gieseck RL, Jiwrajka N, White SD, Karmele EP, Redes J, Vannella KM, Henderson NC, Wynn TA, Hart KM.

J Pathol. 2019 May;248(1):16-29. doi: 10.1002/path.5215. Epub 2019 Jan 24.

PMID:
30536905
3.

Type 2 immunity in tissue repair and fibrosis.

Gieseck RL 3rd, Wilson MS, Wynn TA.

Nat Rev Immunol. 2018 Jan;18(1):62-76. doi: 10.1038/nri.2017.90. Epub 2017 Aug 30. Review.

PMID:
28853443
4.

Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids.

Sampaziotis F, Justin AW, Tysoe OC, Sawiak S, Godfrey EM, Upponi SS, Gieseck RL 3rd, de Brito MC, Berntsen NL, Gómez-Vázquez MJ, Ortmann D, Yiangou L, Ross A, Bargehr J, Bertero A, Zonneveld MCF, Pedersen MT, Pawlowski M, Valestrand L, Madrigal P, Georgakopoulos N, Pirmadjid N, Skeldon GM, Casey J, Shu W, Materek PM, Snijders KE, Brown SE, Rimland CA, Simonic I, Davies SE, Jensen KB, Zilbauer M, Gelson WTH, Alexander GJ, Sinha S, Hannan NRF, Wynn TA, Karlsen TH, Melum E, Markaki AE, Saeb-Parsy K, Vallier L.

Nat Med. 2017 Aug;23(8):954-963. doi: 10.1038/nm.4360. Epub 2017 Jul 3.

5.

Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β.

Hart KM, Fabre T, Sciurba JC, Gieseck RL 3rd, Borthwick LA, Vannella KM, Acciani TH, de Queiroz Prado R, Thompson RW, White S, Soucy G, Bilodeau M, Ramalingam TR, Arron JR, Shoukry NH, Wynn TA.

Sci Transl Med. 2017 Jun 28;9(396). pii: eaal3694. doi: 10.1126/scitranslmed.aal3694.

PMID:
28659437
6.

Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis.

Gieseck RL 3rd, Ramalingam TR, Hart KM, Vannella KM, Cantu DA, Lu WY, Ferreira-González S, Forbes SJ, Vallier L, Wynn TA.

Immunity. 2016 Jul 19;45(1):145-58. doi: 10.1016/j.immuni.2016.06.009. Epub 2016 Jul 12.

7.

Enhanced protection from fibrosis and inflammation in the combined absence of IL-13 and IFN-γ.

Ramalingam TR, Gieseck RL, Acciani TH, M Hart K, Cheever AW, Mentink-Kane MM, Vannella KM, Wynn TA.

J Pathol. 2016 Jul;239(3):344-54. doi: 10.1002/path.4733. Epub 2016 Jun 10.

8.

TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma.

Choy DF, Hart KM, Borthwick LA, Shikotra A, Nagarkar DR, Siddiqui S, Jia G, Ohri CM, Doran E, Vannella KM, Butler CA, Hargadon B, Sciurba JC, Gieseck RL, Thompson RW, White S, Abbas AR, Jackman J, Wu LC, Egen JG, Heaney LG, Ramalingam TR, Arron JR, Wynn TA, Bradding P.

Sci Transl Med. 2015 Aug 19;7(301):301ra129. doi: 10.1126/scitranslmed.aab3142.

PMID:
26290411
9.

Generation of Hepatocytes from Pluripotent Stem Cells for Drug Screening and Developmental Modeling.

Gieseck RL 3rd, Vallier L, Hannan NR.

Methods Mol Biol. 2015;1250:123-42. doi: 10.1007/978-1-4939-2074-7_9.

PMID:
26272139
10.

Disease modeling using human induced pluripotent stem cells: lessons from the liver.

Gieseck RL 3rd, Colquhoun J, Hannan NR.

Biochim Biophys Acta. 2015 Jan;1851(1):76-89. doi: 10.1016/j.bbalip.2014.05.010. Epub 2014 Jun 2. Review.

11.

Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture.

Gieseck RL 3rd, Hannan NR, Bort R, Hanley NA, Drake RA, Cameron GW, Wynn TA, Vallier L.

PLoS One. 2014 Jan 22;9(1):e86372. doi: 10.1371/journal.pone.0086372. eCollection 2014.

12.

Counting the number of magnesium ions bound to the surface-immobilized thymine oligonucleotides that comprise spherical nucleic acids.

Walter SR, Young KL, Holland JG, Gieseck RL, Mirkin CA, Geiger FM.

J Am Chem Soc. 2013 Nov 20;135(46):17339-48. doi: 10.1021/ja406551k. Epub 2013 Nov 12.

PMID:
24156735
13.

A humidity-sensitive hydrogel-Bacillus spore composite for micropatterning of biomolecular gradients.

Gieseck RL, Chan BD, Savran CA.

Rev Sci Instrum. 2013 Aug;84(8):085003. doi: 10.1063/1.4817971.

PMID:
24007098
14.

Spore-terminated cantilevers for chemical patterning on complex architectures.

Kramer MA, Gieseck RL, Andrews B, Ivanisevic A.

J Am Chem Soc. 2011 Jun 29;133(25):9627-9. doi: 10.1021/ja201331j. Epub 2011 Jun 2.

PMID:
21619041
15.

Mechanism of proton relaxation for enzyme-manipulated, multicomponent gold-magnetic nanoparticle chains.

Jaganathan H, Gieseck RL, Hudson K, Kellogg M, Ramaswamy AK, Raver KE, Smith T, Vacchiano AN, Wager A, Ivanisevic A.

Chemphyschem. 2010 Dec 3;11(17):3664-72. doi: 10.1002/cphc.201000397.

PMID:
21077085
16.

Characterizing proton relaxation times for metallic and magnetic layer-by-layer-coated, DNA-templated nanoparticle chains.

Jaganathan H, Gieseck RL, Ivanisevic A.

Nanotechnology. 2010 Jun 18;21(24):245103. doi: 10.1088/0957-4484/21/24/245103. Epub 2010 May 20.

PMID:
20484793

Supplemental Content

Loading ...
Support Center